Table 1.
Patient baseline characteristics
| Total, n (%) (n = 43) | |
|---|---|
| Age (y, median) | 61 ± 9.9 |
| Sex (male) | 38 (88.4) |
| ECOG PS | |
| 0 | 16 (37.2) |
| 1 | 24 (55.8) |
| 2 | 3 (7.0) |
| Primary tumor sites | |
| Hypopharynx | 16 (37.2) |
| Nasopharynx | 15 (34.9) |
| Oropharynx | 8 (18.6) |
| Oral cavity | 2 (4.7) |
| Larynx | 1 (2.3) |
| Paranasal sinus | 1 (2.3) |
| Stage of primary tumor | |
| T1 | 6 (14.0) |
| T2 | 18 (41.8) |
| T3 | 5 (11.6) |
| T4 | 14 (32.6) |
| Nodal stage | |
| N0 | 2 (4.7%) |
| N1 | 15 (34.9%) |
| N2 | 23 (53.4%) |
| N3 | 3 (7.0%) |
| Overall stage of disease | |
| II | 3 (7.0) |
| III | 13 (30.2) |
| IVA | 17 (39.5) |
| IVB | 10 (23.3) |
ECOG PS Eastern Cooperative Oncology Group Performance Status